News

SPANZA ADVISORY ON TRAMADOL:  May 2017

Subsequent to the FDA announcement on 20th April regarding the use of Codeine and Tramadol in children and in breastfeeding women (https://www.fda.gov/Drugs/DrugSafety/ucm549679.htm) SPANZA has asked groups of experts to review the literature and produce two advisory statements. The first is regarding the use of Tramadol in children. The second is regarding the use of Tramadol during breastfeeding and in the neonate. These documents arose from a request for advice from our membership, associated societies and medication regulatory authorities.

SPANZA statements on Tramadol

1. Recommendations following FDA warnings about Tramadol use in Children

2. Use of Tramadol during breastfeeding and in the Neonate

 

NEWSLETTERS

Since Summer 2012 the SPANZA newsletter changed to an electronic format which is sent out via broadcast mail.

Contributions to the Newsletter are welcome from all members.

If you would like to send a contribution you can send it to the SPANZA Secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it..

Previous Newsletters

 2012

2011

 2010

 2009

2008

2007